Literature DB >> 17716328

Use of topiramate for glossodynia.

Antonio Siniscalchi1, Luca Gallelli, Norma Maria Marigliano, Paola Orlando, Giovambattista De Sarro.   

Abstract

INTRODUCTION: Glossodynia is a multifunctional disorder characterized by painful sensations in the mouth and throat and especially on the tongue. It is commonly cured by long-term therapy with systemic regimens of anxiolytics, antidepressants, and anticonvulsants. CASE: We report here the case of a 65-year-old woman with a 4-month history of glossodynia. Clinical and laboratory evaluations performed the diagnosis of idiopathic glossodynia, and several treatments with carbamazepine and then with gabapentin induced the development of serious adverse reaction. Only treatment with topiramate has been able to induce a complete improvement of symptoms. DISCUSSION: The pathogenesis of idiopathic glossodynia remains unclear, since it recently has been suggested as a possible neuropathic basis of burning mouth syndrome, demonstrating an altered excitability in the trigeminal nociceptive pathway at peripheral and/or central nervous system level. The various mechanisms of topiramate, which act at different neural transmission levels, blocking sodium and calcium channels, enhancing GABA concentration, and decreasing glutamate function at postsynaptic site, may explain the effects of topiramate in our patient.
CONCLUSION: Therefore, we suggest that topiramate could represent a useful therapeutic option in the treatment of glossodynia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716328     DOI: 10.1111/j.1526-4637.2006.00152.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  10 in total

1.  Chronic Orofacial Pain: Burning Mouth Syndrome and Other Neuropathic Disorders.

Authors:  Raymond C Tait; McKenzie Ferguson; Christopher M Herndon
Journal:  J Pain Manag Med       Date:  2017-01-30

Review 2.  Burning mouth syndrome.

Authors:  José G Speciali; Juliana Stuginski-Barbosa
Journal:  Curr Pain Headache Rep       Date:  2008-08

Review 3.  Insight into the Role of Psychological Factors in Oral Mucosa Diseases.

Authors:  Yuexin Guo; Boya Wang; Han Gao; Chengwei He; Rongxuan Hua; Lei Gao; Yixuan Du; Jingdong Xu
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

4.  Loss of taste and smell during treatment with topiramate.

Authors:  A Ghanizadeh
Journal:  Eat Weight Disord       Date:  2009 Jun-Sep       Impact factor: 4.652

5.  Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosis.

Authors:  Antonio Siniscalchi; Luca Gallelli; Giovambattista De Sarro
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

Review 6.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

7.  Topiramate induced peripheral neuropathy: A case report and review of literature.

Authors:  Sherifa Ahmed Hamed
Journal:  World J Clin Cases       Date:  2017-12-16       Impact factor: 1.337

8.  Feline orofacial pain syndrome (FOPS): a retrospective study of 113 cases.

Authors:  Clare Rusbridge; Sarah Heath; Danièlle A Gunn-Moore; Susan Penelope Knowler; Norman Johnston; Angus Kennedy McFadyen
Journal:  J Feline Med Surg       Date:  2010-05-06       Impact factor: 2.015

9.  Pregabalin in post traumatic neuropathic pain: Case studies.

Authors:  Rakesh Kumar Singh; Vijay Prakash Sinha; U S Pal; Sharad C Yadav; Maneesh K Singh
Journal:  Natl J Maxillofac Surg       Date:  2012-01

Review 10.  The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option.

Authors:  Antonio Siniscalchi; Antonello Bonci; Nicola Biagio Mercuri; Domenico Pirritano; Aida Squillace; Giovambattista De Sarro; Luca Gallelli
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.